UK markets closed

Poxel S.A. (0RA2.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
1.60000.0000 (0.00%)
At close: 07:29AM GMT
Full screen
Previous close1.6000
Open5.6442
Bid0.0000 x 0
Ask0.0000 x 0
Day's range1.6000 - 1.6000
52-week range0.3530 - 1.6000
Volume78,599
Avg. volume3,695
Market cap394,955
Beta (5Y monthly)1.41
PE ratio (TTM)N/A
EPS (TTM)-0.8300
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Poxel Provides Corporate Update and Reports Cash and Revenue for the Third Quarter and Nine Months 2023

    LYON, France, November 08, 2023--Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, today provided a corporate update and announced its cash position and revenue for the third quarter and the nine months ended September 30, 2023.

  • Business Wire

    Poxel Announces its Participation at Upcoming Investor Conferences

    LYON, France, October 12, 2023--Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, today announced that it will participate at two upcoming investor conferences.

  • Business Wire

    Poxel Announces its Participation at Upcoming Scientific Conference

    LYON, France, October 02, 2023--Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, today announced that it will participate at the upcoming 12th International Meeting on AMPK on October 4th, 2023.